GGrantIndex
← Search

X-RAY CRYSTALLOGRAPHY

$272,345P30FY2013CANIH

Sloan-Kettering Inst Can Research, New York NY

Investigators

Linked publications, trials & patents

Trial NCT03699631Trial NCT02595918Trial NCT02417701Trial NCT02219737Trial NCT02152995Trial NCT01979523Trial NCT01947023Trial NCT01902160Trial NCT01705340Trial NCT01643278Trial NCT01638546Trial NCT01587352Trial NCT01585805Trial NCT01326702Trial NCT01281865Trial NCT01196416Trial NCT01154452Trial NCT01143402Trial NCT01119599Trial NCT01051557Trial NCT01026623Trial NCT01016015Trial NCT00957905Trial NCT00866177Trial NCT00729157Trial NCT00639509Trial NCT00601692Trial NCT00589472Trial NCT00570401Trial NCT00567229Trial NCT00550628Trial NCT00541034Trial NCT00528450Trial NCT00522301Trial NCT00521014Trial NCT00519974Trial NCT00514254Trial NCT00498927Trial NCT00483678Trial NCT00474994Trial NCT00471679Trial NCT00471601Trial NCT00470574Trial NCT00470470Trial NCT00462982Trial NCT00462501Trial NCT00459875Trial NCT00458705Trial NCT00453310Trial NCT00450827Trial NCT00416351Trial NCT00404365Trial NCT00398138Trial NCT00397904Trial NCT00369174Trial NCT00354679Trial NCT00334893Trial NCT00324480Trial NCT00245102Trial NCT00104845Trial NCT00090337Trial NCT00089245Trial NCT00087009Trial NCT00072345Trial NCT00072319Trial NCT00070057Trial NCT00067015Trial NCT00062374Trial NCT00059891Trial NCT00058253Trial NCT00054132Trial NCT00046917Trial NCT00040898Trial NCT00040872Trial NCT00039286Trial NCT00037011Trial NCT00036933Trial NCT00028730Trial NCT00024258Trial NCT00023764Trial NCT00020891Trial NCT00016146Trial NCT00014534Trial NCT00014469Trial NCT00008294Trial NCT00008242Trial NCT00006044Trial NCT00004245Trial NCT00004066Trial NCT00003923Trial NCT00003819Trial NCT00003173Trial NCT00003023Trial NCT00002981Trial NCT00002930Trial NCT00002766Trial NCT00002738Trial NCT00002718Trial NCT00002663Trial NCT00002558

Abstract

The primary goal of the X-ray Crystallography Core is to enable and facilitate the research of MSKCC laboratories that use X-ray crystallography as a tool to address questions in their research programs. The facility maintains in-house equipment for data collection, processing and structure determination, implements a wide range of crystallographic and structure analysis software packages, provides long-term regular access to state-of-the-art synchrotron beamlines through participation in multi-institutional consortia at two national laboratory locations, provides training and technical assistance to users of both the in-house and remote facilities, and provides expertise in structural biology and modeling and guidance to non-structural MSKCC laboratories that benefit from the use of available structures in the design and interpretation of experiments. Structural biology has been playing an increasing role in understanding the many biological processes important in cancer and in accelerating the pace of anti-cancer drug discovery. In the post-genomic era, the need for structural data to understand biological function and regulation, to provide scaffolds for the design or improvement of candidate anticancer compounds, and to help identify molecular function will increase with the application of massively parallel data acquisition tools such as DMA arrays, global protein-protein interaction maps and large scale identification of cancer-related genes. This will require increased throughput from conventional X-ray crystallography facilities, and new, state-of-the-art synchrotron facilities to accelerate structure determination and to allow the study of increasingly large and complex structures and macromolecular assemblies.

View original record on NIH RePORTER →